These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 16971967)

  • 1. RNA interference for the treatment of cancer.
    Putral LN; Gu W; McMillan NA
    Drug News Perspect; 2006; 19(6):317-24. PubMed ID: 16971967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA interference in cancer.
    Gartel AL; Kandel ES
    Biomol Eng; 2006 Mar; 23(1):17-34. PubMed ID: 16466964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [RNA interference (RNAi) and its therapeutic potential in cancer].
    Vázquez-Vega S; Contreras-Paredes A; Lizano-Soberón M; Amador-Molina A; García-Carrancá A; Sánchez-Suárez LP; Benítez-Bribiesca L
    Rev Invest Clin; 2010; 62(1):81-90. PubMed ID: 20415062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short interfering RNAs as a tool for cancer gene therapy.
    Izquierdo M
    Cancer Gene Ther; 2005 Mar; 12(3):217-27. PubMed ID: 15550938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-specific shRNA delivery: a novel approach for gene therapy in cancer.
    Ghatak S; Hascall VC; Berger FG; Penas MM; Davis C; Jabari E; He X; Norris JS; Dang Y; Markwald RR; Misra S
    Connect Tissue Res; 2008; 49(3):265-9. PubMed ID: 18661357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospects of RNA interference therapy for cancer.
    Pai SI; Lin YY; Macaes B; Meneshian A; Hung CF; Wu TC
    Gene Ther; 2006 Mar; 13(6):464-77. PubMed ID: 16341059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA interference advances to early-stage clinical trials.
    Brower V
    J Natl Cancer Inst; 2010 Oct; 102(19):1459-61. PubMed ID: 20870977
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.
    Li SD; Huang L
    Mol Pharm; 2006; 3(5):579-88. PubMed ID: 17009857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular therapy in the microRNA era.
    Wurdinger T; Costa FF
    Pharmacogenomics J; 2007 Oct; 7(5):297-304. PubMed ID: 17189960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of RNAi technology to knockdown gene expression in vivo in mammalians].
    Zhang AH; Liu GQ
    Sheng Li Ke Xue Jin Zhan; 2004 Apr; 35(2):125-9. PubMed ID: 15285417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonviral delivery vehicles for use in short hairpin RNA-based cancer therapies.
    Vorhies JS; Nemunaitis J
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):373-82. PubMed ID: 17338656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.
    Mahato RI; Cheng K; Guntaka RV
    Expert Opin Drug Deliv; 2005 Jan; 2(1):3-28. PubMed ID: 16296732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential use of RNA interference in cancer therapy.
    Phalon C; Rao DD; Nemunaitis J
    Expert Rev Mol Med; 2010 Aug; 12():e26. PubMed ID: 20716384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted delivery of small interfering RNA: approaching effective cancer therapies.
    Pirollo KF; Chang EH
    Cancer Res; 2008 Mar; 68(5):1247-50. PubMed ID: 18316585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. siRNA-based approaches in cancer therapy.
    Devi GR
    Cancer Gene Ther; 2006 Sep; 13(9):819-29. PubMed ID: 16424918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic RNA interference for neurodegenerative diseases].
    González-Alegre P
    Rev Neurol; 2008 Dec 16-31; 47(12):641-7. PubMed ID: 19085881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allele-specific RNA interference for neurological disease.
    Rodriguez-Lebron E; Paulson HL
    Gene Ther; 2006 Mar; 13(6):576-81. PubMed ID: 16355113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNAi: a novel antisense technology and its therapeutic potential.
    Dallas A; Vlassov AV
    Med Sci Monit; 2006 Apr; 12(4):RA67-74. PubMed ID: 16572063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of RNAi to cancer therapy].
    Tan YL; Yin JQ
    Yao Xue Xue Bao; 2005 Mar; 40(3):193-8. PubMed ID: 15952587
    [No Abstract]   [Full Text] [Related]  

  • 20. Blocking cancer with RNA interference moves toward the clinic.
    Hede K
    J Natl Cancer Inst; 2005 May; 97(9):626-8. PubMed ID: 15870429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.